The syringes market is anticipated to cross a valuation of US$ 22,487 million in 2023. The market is likely to surpass US$ 54,219.8 million by 2033, at a healthy CAGR of 9.2% from 2023 to 2033.
Drivers:
Restraints:
Opportunities:
Trends:
| Attribute | Details |
|---|---|
| Syringes Market Size 2023 | US$ 22,487 million |
| Syringes Market Size 2033 | US$ 54,219.8 million |
| Syringes Market Value CAGR (2023 to 2033) | 9.2% |
| Collective Value Share: Top 5 Companies (2023E) | 20 to 25% |
Syringes are among the most prevalent healthcare products medical professionals use to inject liquids and semi-solid compositions into the bodies of humans and animals. They are also used for withdrawing fluids and cleaning wounds or body cavities.
Although syringes have been in use for quite an extended period, there has been a rapid surge in demand for syringes during the last several years due to the rising usage of disposable syringes, an increase in the number of mass vaccination programs, and the growing trend of self-administration of injections.
Leading syringe manufacturers continuously innovate to develop novel technologies with better features. They are partnering and collaborating with syringe filling machines and syringe label manufacturers to expand their customer base.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights, the global syringes industry is anticipated to grow at a healthy CAGR of 9.2% between 2023 and 2033, compared to the 7.6% registered between 2018 and 2022.
The rise in vaccination administration rates worldwide, expansion of the healthcare industry, increasing incidence of chronic and infectious diseases, growing popularity of disposable syringes, and rising preference for injections due to their faster actions are some of the major factors underpinning the growth of the syringes industry.
Besides this, the flourishing insulin syringes industry and the rising penetration of prefilled syringes market across developing regions positively influence medical syringes sales.
Syringes have become widely used across hospitals, research laboratories, drug manufacturing, and clinical research laboratories. They are increasingly used for administering a wide range of healthcare products and withdrawing body fluids required for disease diagnosis or research purposes. Thus, the rising prevalence of chronic and infectious diseases is likely to therefore continue to boost the sales of syringes during the forecast period.
Consequently, the availability of different types of syringes, like disposable and reusable ones with various capacities, is positively impacting the growth of the syringe market. End users can easily choose any syringe type as per their specific requirements.
Similarly, various initiatives are being launched by governments and healthcare organizations like GAVI to enable access to essential vaccines for people. For instance, in December 2021, the United States Agency for International Development (USAID) announced the INITIATIVE FOR GLOBAL VACCINE ACCESS (GLOBAL VAX) to accelerate vaccine access and delivery assistance worldwide.
The expansion of the healthcare industry worldwide, changing attitudes towards vaccinations, advancements in the syringes technologies market, the rising popularity of cyclic olefin polymers (COP) polymer syringes, and the growing need for reducing the mortality rate of some lethal diseases are likely to boost the demand for syringes during the forthcoming years. According to the WHO, immunization prevents around 4-5 deaths yearly.
Based on the abovementioned factors, the syringes industry is projected to surpass US$ 54,219.8 million during the forecast period (2023 to 2033).
| Region | United States |
|---|---|
| Market Share in 2022 | 25.7% |
| Regional Trends | Increasing adoption of safety syringes |
| Region | Germany |
|---|---|
| Market Share in 2022 | 8.2% |
| Regional Trends | Emphasis on quality and precision, focus on sustainable manufacturing practices |
| Region | Japan |
|---|---|
| Market Share in 2022 | 3.8% |
| Regional Trends | Technological innovation, focus on producing innovative syringe designs |
| Region | Australia |
|---|---|
| Market Share in 2022 | 1.5% |
| Regional Trends | Growing adoption of prefilled syringes |
Escalation in the Usage of Self-Administrative Drugs Pushing Sales of Syringes in the United States
According to Future Market Insights, the United States syringes market is expected to create an absolute growth opportunity of US$ 5.7 billion by 2033 and is projected to expand by 2.5X during the forecast period (2023 to 2033).
In 2022, the United States had a sizeable market share of 25.7%, making it one of the most significant players in the syringes industry. Rising sales of syringes across the country can be attributed to the surge in chronic and infectious diseases, increasing usage of self-administered drugs, availability of standard syringes, presence of leading syringes manufacturers, and expansion of markets like prefilled syringes industry, home healthcare market, and insulin syringes industry.
The rising prevalence of chronic and infectious diseases such as diabetes and flu is a major factor boosting the growth of the syringe market. According to the CDC's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 6 in 10 adults in the United States have a chronic disease. People spend billions of dollars annually on insulin injections, flu vaccines, etc.
Germany contributed 8.2% to the market share in 2022, highlighting its significant presence in the syringes industry. A key trend observed in the region is the emphasis on quality and precision. German manufacturers prioritize using advanced manufacturing technologies and stringent quality control measures to ensure the production of high-quality syringes. Additionally, there is a growing focus on sustainable manufacturing practices, including using eco-friendly materials and energy-efficient processes.
Japan accounted for 3.8% of the market share in 2022, establishing its importance in the global syringes industry. The region is known for its technological innovation in various sectors, including healthcare. Japanese manufacturers are at the forefront of producing innovative syringe designs that offer improved functionality, precision, and ease of use in the syringe industry. The continuous development of advanced materials, such as self-lubricating plastics and biocompatible coatings, has also contributed to the growth of the syringes industry in Japan.
Australia held a market share of 1.5% in 2022, indicating its contribution to the syringes industry. A notable trend in the region is the growing adoption of prefilled syringes. Prefilled syringes offer several advantages, such as reduced medication errors, improved dosage accuracy, and enhanced convenience for healthcare professionals and patients. The increasing demand for self-administered medications and the rise in chronic diseases drive the adoption of prefilled syringes in Australia.
| Region | China |
|---|---|
| CAGR (2023 to 2033) | 6.7% |
| Regional Trends | Shift towards the production of low-cost syringes, adoption of automation in manufacturing |
| Region | India |
|---|---|
| CAGR (2023 to 2033) | N/A |
| Regional Trends | Rapid growth, production of eco-friendly and cost-effective syringes, adoption of digital solutions and telemedicine services |
| Region | United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 3.7% |
| Regional Trends | Stringent regulatory standards |
China recorded a CAGR of 6.7% in 2022, positioning itself as a notable player in the global syringes market. The country has witnessed a significant shift towards producing low-cost syringes, which cater to domestic and international markets. Chinese manufacturers leverage economies of scale and advanced manufacturing capabilities to offer competitive pricing without compromising quality. Additionally, there is a growing adoption of automation in syringe manufacturing processes, leading to increased production efficiency and cost savings.
The United Kingdom held a market share of 3.7% in 2022, establishing its prominence in the global syringes market. Stringent regulatory standards and a strong emphasis on product quality characterize the region. Manufacturers in the United Kingdom are focused on developing advanced syringe technologies that prioritize patient safety and improve the overall healthcare experience. The growing demand for self-administration syringes and the rise in chronic diseases are driving the market in the region. The United Kingdom's robust healthcare infrastructure and strategic partnerships with pharmaceutical companies contribute to its competitive edge in the syringes industry.
High Consumption of Vaccines Fueling the Demand for Disposable Syringes in India
Amid changing attitudes towards vaccination, a rapidly growing population, growing health awareness among people, the surge in numerous diseases, and rapid expansion of the disposable syringes industry, India is set to account for over 35% share of the South Asia syringes industry during the forecast period. Further, a CAGR of 10.5% has been predicted for the India syringes industry by FMI throughout the forecast period.
India is among the fastest-growing economies in the world, with an enormous population of over 1.38 billion. The country is becoming an ideal destination for disposable syringes. Factors such as increasing government initiatives to vaccinate every newborn child, the significant presence of syringe manufacturers, and awareness about the latest syringes market trends are favoring the growth of the syringes industry in India.
Principal Consultant
Growing Threat of Diseases Transmission Spurring the Sales of Syringes
Based on material, the glass syringes segment accounted for the largest share of the global syringes industry in 2022. This is attributable to the rising usage of glass material for making prefilled syringes supported by the rapid expansion of prefilled syringes drug molecules market worldwide.
However, the plastic syringes segment is expected to grow at a much higher CAGR during the forecast period, owing to the rising preference for disposable and cost-effective syringes, increasing usage of plastic syringes during vaccination drives, and the flourishing plastic syringes industry.
Besides this, various advantages, such as high impact resistance and the user-friendly nature of plastic syringes make them ideal for adoption.
Disposable Syringes to Remain Highly-Sought-After Syringes Type Amid Rising Need for Curbing Disease Transmission
By syringe type, the disposable syringes segment is likely to continue dominating the global syringes industry. This is owing to the rising prevalence of contagious diseases, increasing health awareness among people, expanding disposable syringes, and growing need to prevent disease spread.
FMI predicts the disposable syringe segment to account for around 86.5% share of the syringes industry by 2033, thereby creating an incremental opportunity of US$ 25.3 billion during the forecast period.
Most of the Medical Syringe Sales Remain Concentrated in Hospitals
By end use, the hospital's segment is likely to expand by 2.7X in terms of value by the end of the forecast period. Furthermore, the study predicts the overall sales of syringes in the hospital's segment to grow at 9.3% CAGR between 2023 and 2033, surpassing a valuation of US$ 23.9 billion by the end of 2033.
Factors such as a rapid increase in the number of hospitals worldwide, the growing preference of people to opt for treatments at hospitals, and the rising usage of syringes for numerous purposes in hospitals are triggering the growth of this segment.
The syringes industry is marked by intense competition, with numerous players vying for market share. Key companies are constantly innovating and introducing new syringe technologies to stay at the forefront of the market. These companies invest in research and development, manufacturing capabilities, and distribution networks to gain a competitive advantage.
Despite the promising growth prospects, companies in the syringes industry face several challenges. Some of the key challenges include stringent regulatory requirements, particularly related to product safety and quality control. The need for compliance with complex regulations can pose challenges for both established players and new entrants. Market saturation and price pressures also create additional hurdles for companies striving to differentiate themselves and maintain profitability.
The syringes industry presents attractive investment opportunities for existing players and new entrants. The growing demand for advanced syringe technologies, driven by factors such as the increasing prevalence of chronic diseases and the expanding healthcare infrastructure in developing regions, opens avenues for investment. Companies focusing on research and development, product innovation, and strategic partnerships can capitalize on these opportunities and gain a competitive edge in the market.
Recent Developments by Key Players in Syringes Market:
How to Scale Businesses in the Syringes Market?
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million in value |
| Report Coverage | Market forecast, company share analysis, competition intelligence, Drivers, Restraints, Opportunities and Threats analysis, market dynamics and challenges, and strategic growth initiatives |
| Key Segments Covered | Material, Syringe Type, Capacity, End Use, Region |
| Key regions covered | North America, United States, Canada, Rest of North America, Latin America, Brazil, Argentina, Mexico, Rest of Latin America, Western Europe, Germany, United Kingdom, France, Rest of Western Europe, Eastern Europe, Russia, Spain, Rest of Eastern Europe, South Asia Pacific, China, India, Japan, Malaysia, Thailand, Indonesia, South Korea, Rest of South Asia & Pacific, Middle East & Africa, GCC Countries, Turkey, Israel, Rest of the Middle East and Africa(MEA), Rest of the World, Oceania, Africa, South America |
| End Use | Hospitals, Research laboratories, Drug Manufacturing, Clinical Research |
| Key companies profiled | Becton; Dickinson; and Company. Gerresheimer AG; Braun Medical Inc.; Schott AG; DWK Life Sciences; CODAN Medizinische Geräte GmbH & Co KG; Cardinal Health Inc.; CHEMI S.P.A.; Terumo Corporation; NIPRO Corporation; Hindustan Syringes & Medical Devices Ltd. |
| Customization & pricing | Available upon request |
The increasing prevalence of chronic diseases, Advancements in syringe materials, and the development of healthcare facilities drive market growth.
Strict regulations and quality standards, a shortage of trained healthcare professionals capable of administering injections, and fluctuations in the prices of raw materials.
Needle-free injection technologies like jet injectors and micro-needle patches are gaining traction globally.
The market is forecast to register a CAGR of 9.2% through 2033.
Investments in research and development, manufacturing capabilities, and distribution networks to gain a competitive advantage.
India, Japan, and China dominate the Asian market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Material, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Material, 2023 to 2033 5.3.1. Glass 5.3.2. Plastic 5.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Syringe Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Syringe Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Syringe Type, 2023 to 2033 6.3.1. Disposable 6.3.2. Reusable 6.4. Y-o-Y Growth Trend Analysis By Syringe Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Syringe Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis by Capacity, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Capacity, 2023 to 2033 7.3.1. Small Volume (1-10 ml) 7.3.2. Medium Volume (11-20 ml) 7.3.3. Large Volume (Above 20ml) 7.4. Y-o-Y Growth Trend Analysis by Capacity, 2018 to 2022 7.5. Absolute $ Opportunity Analysis by Capacity, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033 8.3.1. Hospitals 8.3.2. Research laboratories 8.3.3. Drug Manufacturing 8.3.4. Clinical Research 8.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East & Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Material 10.2.3. By Syringe Type 10.2.4. By Capacity 10.2.5. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Material 10.3.3. By Syringe Type 10.3.4. By Capacity 10.3.5. By End Use 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Argentina 11.2.1.4. Rest of Latin America 11.2.2. By Material 11.2.3. By Syringe Type 11.2.4. By Capacity 11.2.5. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Material 11.3.3. By Syringe Type 11.3.4. By Capacity 11.3.5. By End Use 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. United Kingdom 12.2.1.2. Germany 12.2.1.3. France 12.2.1.4. Italy 12.2.1.5. Spain 12.2.1.6. Rest of Western Europe 12.2.2. By Material 12.2.3. By Syringe Type 12.2.4. By Capacity 12.2.5. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Material 12.3.3. By Syringe Type 12.3.4. By Capacity 12.3.5. By End Use 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Russia 13.2.1.2. Poland 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Material 13.2.3. By Syringe Type 13.2.4. By Capacity 13.2.5. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Material 13.3.3. By Syringe Type 13.3.4. By Capacity 13.3.5. By End Use 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Material 14.2.3. By Syringe Type 14.2.4. By Capacity 14.2.5. By End Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Material 14.3.3. By Syringe Type 14.3.4. By Capacity 14.3.5. By End Use 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Material 15.2.3. By Syringe Type 15.2.4. By Capacity 15.2.5. By End Use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Material 15.3.3. By Syringe Type 15.3.4. By Capacity 15.3.5. By End Use 15.4. Key Takeaways 16. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. Iran 16.2.1.2. Turkey 16.2.1.3. Rest of MEA 16.2.2. By Material 16.2.3. By Syringe Type 16.2.4. By Capacity 16.2.5. By End Use 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Material 16.3.3. By Syringe Type 16.3.4. By Capacity 16.3.5. By End Use 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Material 17.1.2.2. By Syringe Type 17.1.2.3. By Capacity 17.1.2.4. By End Use 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Material 17.2.2.2. By Syringe Type 17.2.2.3. By Capacity 17.2.2.4. By End Use 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Material 17.3.2.2. By Syringe Type 17.3.2.3. By Capacity 17.3.2.4. By End Use 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Material 17.4.2.2. By Syringe Type 17.4.2.3. By Capacity 17.4.2.4. By End Use 17.5. Argentina 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Material 17.5.2.2. By Syringe Type 17.5.2.3. By Capacity 17.5.2.4. By End Use 17.6. United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Material 17.6.2.2. By Syringe Type 17.6.2.3. By Capacity 17.6.2.4. By End Use 17.7. Germany 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Material 17.7.2.2. By Syringe Type 17.7.2.3. By Capacity 17.7.2.4. By End Use 17.8. France 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Material 17.8.2.2. By Syringe Type 17.8.2.3. By Capacity 17.8.2.4. By End Use 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Material 17.9.2.2. By Syringe Type 17.9.2.3. By Capacity 17.9.2.4. By End Use 17.10. Spain 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Material 17.10.2.2. By Syringe Type 17.10.2.3. By Capacity 17.10.2.4. By End Use 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Material 17.11.2.2. By Syringe Type 17.11.2.3. By Capacity 17.11.2.4. By End Use 17.12. Poland 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Material 17.12.2.2. By Syringe Type 17.12.2.3. By Capacity 17.12.2.4. By End Use 17.13. Czech Republic 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Material 17.13.2.2. By Syringe Type 17.13.2.3. By Capacity 17.13.2.4. By End Use 17.14. Romania 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Material 17.14.2.2. By Syringe Type 17.14.2.3. By Capacity 17.14.2.4. By End Use 17.15. India 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Material 17.15.2.2. By Syringe Type 17.15.2.3. By Capacity 17.15.2.4. By End Use 17.16. Bangladesh 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Material 17.16.2.2. By Syringe Type 17.16.2.3. By Capacity 17.16.2.4. By End Use 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Material 17.17.2.2. By Syringe Type 17.17.2.3. By Capacity 17.17.2.4. By End Use 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Material 17.18.2.2. By Syringe Type 17.18.2.3. By Capacity 17.18.2.4. By End Use 17.19. China 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Material 17.19.2.2. By Syringe Type 17.19.2.3. By Capacity 17.19.2.4. By End Use 17.20. Japan 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Material 17.20.2.2. By Syringe Type 17.20.2.3. By Capacity 17.20.2.4. By End Use 17.21. South Korea 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Material 17.21.2.2. By Syringe Type 17.21.2.3. By Capacity 17.21.2.4. By End Use 17.22. Iran 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Material 17.22.2.2. By Syringe Type 17.22.2.3. By Capacity 17.22.2.4. By End Use 17.23. Turkey 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Material 17.23.2.2. By Syringe Type 17.23.2.3. By Capacity 17.23.2.4. By End Use 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Material 18.3.3. By Syringe Type 18.3.4. By Capacity 18.3.5. By End Use 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Becton, Dickinson, and Company 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Gerresheimer AG 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Braun Medical Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Schott AG 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. DWK Life Sciences 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. CODAN Medizinische Geräte GmbH & Co KG 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Cardinal Health Inc. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. CHEMI S.P.A. 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Terumo Corporation 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. NIPRO Corporation 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.11. Hindustan & Medical Devices Ltd. 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Packaging Insights
View Reports
Syringes Market
